HK55887A - Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production - Google Patents

Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production

Info

Publication number
HK55887A
HK55887A HK558/87A HK55887A HK55887A HK 55887 A HK55887 A HK 55887A HK 558/87 A HK558/87 A HK 558/87A HK 55887 A HK55887 A HK 55887A HK 55887 A HK55887 A HK 55887A
Authority
HK
Hong Kong
Prior art keywords
teichomycin
factor
production
pure single
single factors
Prior art date
Application number
HK558/87A
Other languages
English (en)
Inventor
Borghi Angelo
Pallanza Rosa
Coronelli Carolina
Cassani Giovanni
Original Assignee
Gruppo Lepetit S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit S.P.A. filed Critical Gruppo Lepetit S.P.A.
Publication of HK55887A publication Critical patent/HK55887A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK558/87A 1982-06-08 1987-07-30 Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production HK55887A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8216590 1982-06-08

Publications (1)

Publication Number Publication Date
HK55887A true HK55887A (en) 1987-08-07

Family

ID=10530888

Family Applications (1)

Application Number Title Priority Date Filing Date
HK558/87A HK55887A (en) 1982-06-08 1987-07-30 Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production

Country Status (32)

Country Link
US (1) US4542018A (enExample)
JP (5) JPS591423A (enExample)
KR (1) KR900008246B1 (enExample)
AU (1) AU560966B2 (enExample)
BE (1) BE896993A (enExample)
BG (1) BG60529B2 (enExample)
CA (1) CA1208204A (enExample)
CH (1) CH657139A5 (enExample)
DE (1) DE3320342A1 (enExample)
DK (1) DK159117C (enExample)
ES (2) ES522941A0 (enExample)
FI (1) FI73697C (enExample)
FR (1) FR2528050B1 (enExample)
GB (1) GB2121401B (enExample)
GR (1) GR78267B (enExample)
HK (1) HK55887A (enExample)
HU (1) HU193538B (enExample)
IE (1) IE55025B1 (enExample)
IL (1) IL68819A0 (enExample)
IT (1) IT1212085B (enExample)
LU (1) LU84853A1 (enExample)
MY (1) MY8700002A (enExample)
NL (1) NL8301980A (enExample)
NO (1) NO159104C (enExample)
NZ (1) NZ204480A (enExample)
PH (1) PH19533A (enExample)
PT (1) PT76831B (enExample)
SE (1) SE459094B (enExample)
SG (1) SG70686G (enExample)
SU (1) SU1318170A3 (enExample)
UA (1) UA6025A1 (enExample)
ZA (1) ZA833607B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4696817A (en) * 1983-10-11 1987-09-29 The Dow Chemical Company Extraction of teichomycin A2 from whole culture fermentation broth
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
GB8512795D0 (en) * 1985-05-21 1985-06-26 Lepetit Spa Increasing ratio of components of teicoplanin a2 complex
US4694069A (en) * 1985-09-30 1987-09-15 Smithkline Beckman Corporation Kibdelosporangium aridum SK&F-AAD-609
JPS61241319A (ja) * 1986-04-25 1986-10-27 Kanegafuchi Chem Ind Co Ltd 新規エーテル‐エステルブロツク共重合体を含有する室温硬化性組成物
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
GB8715735D0 (en) * 1987-07-03 1987-08-12 Lepetit Spa De-mannosyl teicoplanin derivatives
US5213797A (en) * 1987-07-13 1993-05-25 Eli Lilly And Company A80407 antibiotics
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
ATE208791T1 (de) 1996-04-23 2001-11-15 Biosearch Italia Spa Chemisches verfahren zur herstellung von amidderivaten von a 40926 antibiotikum
KR100476818B1 (ko) * 2002-07-19 2005-03-17 종근당바이오 주식회사 테이코플라닌 에이 투 정제 방법
AU2003298662A1 (en) * 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1806150A1 (en) * 2006-01-05 2007-07-11 NEED PHARMA S.r.l. Teicoplanin composition
CN102718843B (zh) * 2012-06-30 2014-05-14 华北制药集团新药研究开发有限责任公司 一种替考拉宁单组份的制备方法
CN114112612A (zh) * 2021-10-28 2022-03-01 丽珠集团福州福兴医药有限公司 一种替考拉宁i5杂质的分离纯化方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496386A (en) * 1975-03-05 1977-12-30 Lepetit Spa Antibiotics

Also Published As

Publication number Publication date
JPH02291278A (ja) 1990-12-03
AU560966B2 (en) 1987-04-30
DK159117C (da) 1991-02-11
FI831660L (fi) 1983-12-09
JPH0224278B2 (enExample) 1990-05-29
US4542018A (en) 1985-09-17
FI73697C (fi) 1987-11-09
DK245883D0 (da) 1983-05-31
BE896993A (fr) 1983-12-07
JPH02288887A (ja) 1990-11-28
FR2528050B1 (fr) 1987-03-20
DK159117B (da) 1990-09-03
ES8503689A1 (es) 1985-04-01
MY8700002A (en) 1987-12-31
GB2121401B (en) 1985-09-18
ES536770A0 (es) 1985-08-16
IL68819A0 (en) 1983-09-30
DE3320342C2 (enExample) 1991-07-11
GB8315003D0 (en) 1983-07-06
SE8303211D0 (sv) 1983-06-07
PH19533A (en) 1986-05-20
FR2528050A1 (fr) 1983-12-09
KR900008246B1 (ko) 1990-11-06
GR78267B (enExample) 1984-09-26
AU1496883A (en) 1983-12-15
FI73697B (fi) 1987-07-31
SU1318170A3 (ru) 1987-06-15
JPS591423A (ja) 1984-01-06
IT8321432A0 (it) 1983-06-02
JPH0415238B2 (enExample) 1992-03-17
JPH0517237B2 (enExample) 1993-03-08
NZ204480A (en) 1986-04-11
PT76831A (en) 1983-07-01
HU193538B (en) 1987-10-28
NO831754L (no) 1983-12-09
JPH0517236B2 (enExample) 1993-03-08
BG60529B2 (bg) 1995-07-28
JPH0415237B2 (enExample) 1992-03-17
NO159104C (no) 1988-11-30
DK245883A (da) 1983-12-09
NO159104B (no) 1988-08-22
JPH02288888A (ja) 1990-11-28
IE831329L (en) 1983-12-08
KR840005170A (ko) 1984-11-05
SE8303211L (sv) 1983-12-09
LU84853A1 (fr) 1984-03-07
DE3320342A1 (de) 1983-12-08
FI831660A0 (fi) 1983-05-12
GB2121401A (en) 1983-12-21
ES522941A0 (es) 1985-04-01
NL8301980A (nl) 1984-01-02
CH657139A5 (fr) 1986-08-15
CA1208204A (en) 1986-07-22
SG70686G (en) 1987-07-03
IE55025B1 (en) 1990-04-25
IT1212085B (it) 1989-11-08
UA6025A1 (uk) 1994-12-29
SE459094B (sv) 1989-06-05
PT76831B (en) 1986-04-09
JPH02291279A (ja) 1990-12-03
ZA833607B (en) 1984-03-28
ES8506748A1 (es) 1985-08-16

Similar Documents

Publication Publication Date Title
HK55887A (en) Teichomycin a2 pure single factors 1,2,3,4 and 5 and method for their production
YU55683A (en) Process for expressiation, altering and excreting heterologic proteine by using yeast
AU578593B2 (en) Graft copolymer and method for production thereof
AU2294788A (en) Apparatus for the intensive, controlled production of microorganisms by photosynthesis
ES8703159A1 (es) Procedimiento para preparar antibioticos para el control y prevencion de infecciones helminticas,ectoparasiticas,artro-podas y acaricidas
HUT39480A (en) Process for preparing antibiotic complex a 40926 and pure components thereof i.e. factors pa, pb, a, b and b down o
FI895380A0 (fi) Menetelmä (6R,S)-folinaattien erottamiseksi
DE3781878D1 (de) Antibiotikum-a10255-komplex und faktoren, verfahren, mikroorganismen fuer seine herstellung.
ZA843015B (en) Novel strain of trichoderma harzianum,method of isolating said strain,method of cultivating said strain,novel peptides or compounds produced from said strain,and application of said strain and of said novel peptides or of the product obtained by the cultivation method as a biologically active means in the form of a plant-disease control product
DE3372214D1 (en) Process for producing vitamin b12 by the fermentation technique, and vitamin b12-producing microorganism
HU910071D0 (en) Bismuth-vandate pigments modified by phosphorus, and process for their production
DE3376649D1 (en) Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions
AU5651186A (en) Method of production of magnetized seed, seedlings or the like
EP0146239A3 (en) Bioconversion production of ascorbic acid
DE3560449D1 (en) Substituted 1-propanoles, process for their production, chloroformic-acid esters ad their use
DE3867918D1 (de) Wachstumspromotor fuer bifidobacterium-arten, prozess zu dessen herstellung und verfahren fuer dessen anwendung.
DE3682556D1 (de) Pyrazoloisochinolinderivate, verfahren zu ihrer herstellung und zubereitung zum beeinflussen des pflanzenwachstums.
FR2490672B1 (fr) Microemulsion de substances nutritives, assimilables par des microorganismes, son procede de preparation, et ses applications
HUT50216A (en) Process for producing l-lysine by fermentation
PL252100A1 (en) Method of obtaining novel derivatives of /4-ketothiazolidynylideno-2/-acetamides
AU6280686A (en) Process for the production of a protein-vitamin food supplement from autotrophic micro-organism, in particular for alga spirulina
JPS6462712A (en) Control method for multistage series pump plant group
AU1015088A (en) New compounds, processes for their production and uses thereof
EP0105148A3 (en) Antimicrobial and antitumor antibiotic m 9026 and its pure individual factors 1, 2 and 3
EP0262858A3 (en) Method for production of a growth factor for bifidobacterium sp.

Legal Events

Date Code Title Description
PE Patent expired